Tumor suppressor control of the cancer stem cell niche
Authors:
- 21 December 2015
- journal article
- research article
- Published by Springer Nature in Oncogene
- Vol. 35 (32) , 4165-4178
Abstract
Mammary stem cells (MSCs) expansion is associated with aggressive human breast cancer. The nuclear receptor peroxisome proliferator activated receptor γ (PPARγ) is a breast cancer tumor suppressor, but the mechanisms of this suppression are not completely characterized. To determine whether PPARγ regulates MSC expansion in mammary cancer, we deleted PPARγ expression in the mammary epithelium of an in vivo model of basal breast cancer. Loss of PPARγ expression reduced tumor latency, and expanded the CD24+/CD49fhi MSC population. PPARγ-null mammary tumors exhibited increased angiogenesis, which was detected in human breast cancer. In vivo inhibition of a PPARγ-regulated miR-15a/angiopoietin-1 pathway blocked increased angiogenesis and MSC expansion. PPARγ bound and activated a canonical response element in the miR-15a gene. PPARγ-null tumors were sensitive to the targeted anti-angiogenic drug sunitinib but resistant to cytotoxic chemotherapy. Normalization of tumor vasculature with sunitinib resulted in objective response to cytotoxic chemotherapy. Chemotherapy-treated PPARγ-null mammary tumors exhibited luminal phenotype and expansion of unipotent CD61+ luminal progenitor cells. Transplantation of chemotherapy-treated luminal progenitor cells recapitulated the luminal phenotype. These results have important implications for anti-angiogenic therapy in breast cancer patients.Keywords
This publication has 52 references indexed in Scilit:
- GATA3 suppresses metastasis and modulates the tumour microenvironment by regulating microRNA-29b expressionNature Cell Biology, 2013
- Angiogenetic axis angiopoietins/Tie2 and VEGF in familial breast cancerEuropean Journal of Human Genetics, 2012
- Antiangiogenic agents increase breast cancer stem cells via the generation of tumor hypoxiaProceedings of the National Academy of Sciences, 2012
- Reprogramming of the tumour microenvironment by stromal PTEN-regulated miR-320Nature Cell Biology, 2011
- MiR-148a inhibits angiogenesis by targeting ERBB3Journal of Biomedical Research, 2011
- Biological and Molecular Heterogeneity of Breast Cancers Correlates with Their Cancer Stem Cell ContentCell, 2010
- Argonaute HITS-CLIP decodes microRNA–mRNA interaction mapsNature, 2009
- The inner nuclear envelope as a transcription factor resting placeEMBO Reports, 2007
- Prognostic analysis of tumour angiogenesis, determined by microvessel density and expression of vascular endothelial growth factor, in high-risk primary breast cancer patients treated with high-dose chemotherapyBritish Journal of Cancer, 2007
- Prospective identification of tumorigenic breast cancer cellsProceedings of the National Academy of Sciences of the United States of America, 2003